Rheumatology, Vol 38, 391-396, Copyright © 1999 by British Society for Rheumatology
SM Johnson, S Patel, FE Bruckner and DA Collins
OBJECTIVES: To evaluate measurements of serum and synovial fluid 5'-
nucleotidase (5'N) activity as a marker of general and local inflammation
in arthritis, and to resolve a contradiction in the literature as to
whether or not the activity of 5'N in the synovial fluids of rheumatoid
arthritis (RA) patients is raised in comparison with that in the synovial
fluids of other arthritis patients. METHODS: Assays for 5'N were carried
out in the presence of inhibitors of other phosphatases, AMP deaminase and
of 5'N itself. RESULTS: The 5'N activity in the synovial fluid of RA
patients was both significantly higher (mean 1.7-fold) and had a greater
variance than that in the synovial fluids of other arthritis patients, and
the contradiction in the literature was resolved. There was a strong
correlation between the 5'N activity in the sera of RA patients and their
erythrocyte sedimentation rate. There was no significant correlation
between the 5'N in the serum and synovial fluid for the RA patients, in
marked contrast to the strong correlation between the two 5'N activities
shown by the osteoarthritis patients. The 5'N activity was greater in the
synovial fluid than in the serum for virtually all the patients, showing
that it was being made locally. CONCLUSIONS: The 5'N activity in the serum
(which came mostly from the liver) could be used as a marker of general
inflammation, whereas the 5'N in the synovial fluid was mostly produced
locally, and could be used as a marker of joint inflammation, particularly
for the RA patients.
ORIGINAL PAPERS
5'-Nucleotidase as a marker of both general and local inflammation in rheumatoid arthritis patients
Division of Biochemistry, St George's Hospital and Medical School, London, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Noji, M. Takayama, M. Mizutani, Y. Okamura, H. Takai, A. Karasawa, and H. Kusaka KF24345, an Adenosine Uptake Inhibitor, Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Production and Leukopenia via Endogenous Adenosine in Mice J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
